Denali Advisors LLC Organon & Co. Transaction History

Denali Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$13.78 - $18.8 $80,158 - $109,359	-5,817 Reduced 80.27%	1,430 $26,000
Q3 2023 Oct 19, 2023	BUY	$16.59 - $23.77 $88,540 - $126,860	5,337 Added 279.42%	7,247 $125,000
Q2 2023 Jul 18, 2023	SELL	$19.27 - $24.63 $13,739 - $17,561	-713 Reduced 27.18%	1,910 $39,000
Q1 2023 Apr 21, 2023	SELL	$21.42 - $32.08 $258,817 - $387,622	-12,083 Reduced 82.16%	2,623 $61,000
Q4 2022 Feb 09, 2023	SELL	$23.31 - $28.61 $58,275 - $71,525	-2,500 Reduced 14.53%	14,706 $410,000
Q3 2022 Oct 25, 2022	BUY	$23.4 - $34.25 $311,805 - $456,381	13,325 Added 343.34%	17,206 $403,000
Q2 2022 Jul 18, 2022	BUY	$31.66 - $38.9 $122,872 - $150,970	3,881 New	3,881 $131,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.